NEWS: Chlorpheniramine Naloxone Oxazepam Prednisolone Plendil Insulin. Neomycin Amoxil Furazolidone Thiotepa Dilantin Plendil! Amitriptyline Trandolapril Risperdal Benadryl Naproxen Dulcolax Beclomethasone Morphine Quinidine Aldara Dolasetron Ethanol Acetylcholine Phenacetin! Fenoterol Avalide Diethylpropion Cytomel, Elocon Tolazamide Disopyramide Glimepiride Cycloserine Chlordiazepoxide: Naloxone Cephalothin. Benicar Dextroamphetamine Hexoprenaline Levitra Podofilox Midodrine: Cyproheptadine Isradipine Fenoprofen Cefamandole, Darvocet Granisetron Cefatrizine Estrone Pyridostigmine Butalbital Belladonna Phenylephrine Levlen Trovafloxacin Avodart Warfarin Ethinyl Gemfibrozil. Mephentermine Cefprozil Nylidrin Diphenoxylate Xanax Methantheline Adipex Ibuprofen? Carbachol Dyphylline Chlordiazepoxide Dantrolene? Vytorin Ceftriaxone Phencyclidine Indinavir? Paregoric Demerol Levothyroxine Ceftibuten Iodoquinol Cycrimine Buclizine Mefloquine, Danazol Colace Zoloft Primidone: Viagra Piroxicam Cardizem Cloxacillin Promazine Paromomycin Pilocarpine Butorphanol Pravastatin Toprol Epoprostenol Promazine Digitalis Nizoral Foradil Oxycontin Hydroflumethiazide Enoxaparin Dilaudid Piperidolate Singulair Tretinoin Thiothixene Propylthiouracil Bethanechol Erythrityl Fentanyl Prochlorperazine! Lopressor Dimethindene. Isopropamide Cholestyramine! Demeclocycline Piperacillin Amikacin Prometrium Zileuton Lozol Nitrofurantoin Moxalactam Trimethoprim Sinemet Corticotropin Carbenicillin: Esomeprazole Miconazole Doxepin Hydromorphone Hydromorphone Desyrel! Probucol Echothiophate Ethchlorvynol Hydroxychloroquine! Hydrochlorothiazide Prozac Trimetrexate Somatostatin Adapalene Doxorubicin? Disulfiram Streptomycin Pheniramine Lunesta Ergocalciferol Pargyline Bleomycin Maprotiline Pantothenic Terbinafine Penicillin Acarbose Cerivastatin Amaryl Guanabenz Climara: Mestranol Aminopterin Clotrimazole Chantix Trientine Amantadine Cocaine Heroin Aprotinin Carteolol Mifepristone Oxytetracycline. Naratriptan Xanax: Cosopt Metoprolol, Clomocycline Flagyl Phensuximide Cortisol Botox Acebutolol Ditropan Chlortetracycline Diovan Nialamide! Betamethasone Chlorothiazide Suboxone Ketoprofen Protonix Lotrel! Methamphetamine Dichlorphenamide Perindopril Isocarboxazid: Iodine Prednisone Augmentin Sildenafil! Tacrolimus Tolmetin! Ethinamate Dalteparin Pseudoephedrine Thiabendazole Acarbose Vytorin Norvasc Diethylstilbestrol Nafcillin Acyclovir. Protriptyline Yohimbine Daunorubicin Guaifenesin Sulfasalazine Celiprolol Amoxapine Bricanyl Gatifloxacin Oxybutynin Diethylstilbestrol Demecarium Medrol Concerta Methacycline Vincristine Butorphanol Mucomyst Digoxin Dioxyline Trileptal Methoxsalen Acebutolol Casanthranol: Pediacare Ergocalciferol:

Pricing Rationality in China’s Stock Markets

Many have characterized Chinese stock markets as inefficient, casino-like and speculative. In the November 2007 Pacific Basin Finane Journal Eun and Huang show that China’s markets may be more rational than many credit.

China’s markets, more than others, are characterized by small investors with undiversified portfolios. Only 37% of shares are publicly tradable, and only 10% of listed companies can offer the B- or H- class shares available to foreign investors. In studying various preferences, the authors find the following:

  1. Stocks are priced according to company-specific rather than systematic risk. There are strong size and value effects, similar to the results found in U.S. markets.
  2. Investors will pay a premium for more liquid stocks.
  3. Investors will pay a premium for dividend paying stocks, possibly because dividends may reduce the ability of managers to expropriate funds.
  4. Investors require lower returns for A-share companies that also issue B- or H-shares, possibly because such companies must meet more stringent disclosure requirements.
See also:
  • Estimating the Market Risk Premium Using Arbitrage Pricing Theory
  • The Capital Asset Pricing Model (CAPM)
  • Stock Migration
  • Where is the Value Premium?
  • Affect in a Behavioral Asset Pricing Model
  • Posted on 7th August 2008
    Under: Uncategorized | No Comments »

    Do Market Timing Hedge Funds Time the Market?

    Many studies have questioned the ability of mutual funds and pension funds to time the market. In an article published in the December 2007 Journal of Financial and Quantitative Analysis, Chen and Liang examine the returns of 221 hedge funds self-identified as market timers. They find that, for the 1994-2005 period, evidence supports timing ability - especially in volatile or bear markets.

    The results are robust to model specification and volatility timing. They do not appear to result primarily from option-like trading or luck.

    The authors conclude that the flexible strategies associated with hedge funds are useful for professional market timers, and that funds promising market-timing results are likely to deliver them.

    See also:
  • Alternative Routes to Hedge Fund Return Replication
  • Are Hedge Fund Strategies Just About Leverage?
  • Market Timing by Mutual Funds
  • Determinants of Funds of Hedge Funds Performance
  • Benchmarking Issues for Hedge Funds
  • Posted on 6th August 2008
    Under: Active Management, Alternative Assets, Hedge Funds, Investment Returns, Performance Measurement, Research | No Comments »

    Equity Returns at the Turn of the Month

    Various studies have documented that the four-day period starting with the last trading day of a month and ending on the third trading day of the subsequent month accounts for the bulk of stock market returns. In the March/April 2008 Financial Analysts Journal McConnell and Xu show that this effect has persisted, and is not confined to small capitalization or low priced stocks. It occurs in 31 of the 35 countries they examined and does not appear to be caused by month-end buying pressure as measured by trading volume or equity fund money flows.

    See also:
  • Why Invest in Equities
  • Calculating Returns in a Portfolio
  • The 3-Stage DuPont Model
  • Market Timing by Mutual Funds
  • Calculating Portfolio Returns Under Global Investment Performance Standards (GIPS)
  • Posted on 5th August 2008
    Under: Active Management, Investing in Stocks, Investment Returns, Research, Risk Management, Technical Analysis | No Comments »

    Portfolio Monitoring: Security Characteristics

    Portfolio monitoring includes monitoring changes in the characteristics of individual securities or asset classes. Over time, underlying average returns, volatility and correlations with other asset classes can change. Such changes alter the appropriate mix of assets for meeting an investor’s objectives and constraints. If the changes are perceived as temporary, they may also present opportunities to make tactical changes.

    The market and economic environment also require monitoring. Of particular importance can be the yield curve, market risk premia, central bank policy, and unusual deviations from normal relationships between securities or asset classes.

    See also:
  • Portfolio Monitoring
  • The Portfolio Management Process
  • Identifying Investment Style Through Holdings Based Analysis
  • Portfolio Monitoring: Keeping Up With Changes in Investor Circumstances
  • Portfolio Monitoring and Rebalancing
  • Posted on 4th August 2008
    Under: Active Management, Asset Allocation, Economic Analysis, FInancial Planning, Portfolio Management | No Comments »

    Evaluating Market Quality

    High quality securities markets are those that supply liquidity, transparency and assured completion.

    Liquidity can be defined a number of ways:

    • Tightness (low bid/ask spread)
    • Depth (limited price impact from large trades)
    • Resiliency (rapid adjustments for discrepancies between market price and intrinsic value)

    Transparency means access to quotes is quick, easy and inexpensive. It also requires that trade details (size and price) are rapidly disseminated to the public.

    Assurity of completion simply means that the counterparties of a trade can be trusted to honor the trade.

    See also:
  • Choice of Performance Measure for Hedge Funds
  • Performance Attribution for Fixed Income Managers
  • Earnings Measures and Stock Return Momentum
  • The Portfolio Management Process
  • Evaluating Investment Manager Performance
  • Posted on 3rd August 2008
    Under: Active Management, Institutional Investing, Investing in Stocks, Risk Management, Trading Execution | No Comments »

    The Flow of Information in an Accounting System

    Accounting systems take the cash and accruals from various transactions and generate financial reports and statements.

    The first step is to create journal entries and adjusting entries. The journal is a chronological list of each transaction, the amount, and the accounts affected. Some systems allow entries to include notes or authorizations. Adjustments are typically made at the end of accounting periods to record accruals not yet reflected in the accounting system.

    Next, the general ledger and T-accounts can show the transactions sorted by the accounts affected rather than in chronological order. This can be useful for reviewing the activity in an account such as inventory.

    Third, a trial balance lists the balance of each account on a given date. Unlike a ledger, only the ending balance is presented. Trial balances represent the first step in producing financial statements.

    Finally, financial statements are prepared as a final product of the system, based on the totals from an adjusted trial balance.

    See also:
  • Cash Flow Statement - The Indirect Method
  • What is a Market?
  • Efficient Market Hypothesis: Semi-Strong Form
  • Cash Flow Ratios
  • Computing Free Cash Flow to the Firm from the Statement of Cash Flows
  • Posted on 1st August 2008
    Under: Uncategorized | No Comments »

    Why Apparent Efficient Market Anomalies May Persist

    Persistent mispricings should attract profit-seeking investors to exploit them. This, in turn, should eventually cause the anomaly to disappear. There are several potential reasons for anomalies to persist.

    Misunderstood Mispricings

    Certain anomalies may not have a logical explanation, causing investors to be wary of trying to exploit them.

    Costly Arbitrage

    Particularly for less liquid securities, there may be significant costs involved in trading them. The higher the costs, the greater a mispricing must be in order for arbitrageurs to try to exploit it.

    Insufficient Profit

    Large investors, in particular, may find that certain mispricings do not offer a significant return for the time involved in identifying and exploiting them.

    Trading Restrictions

    Many investors have limits imposed on their activity, such as a prohibition on short selling. Such prohibitions can prevent investors from exploiting opportunities when identified.

    See also:
  • Biases in Detecting Efficient Market Anomalies
  • Are Markets Semistrong Form Efficient?
  • Collective Wisdom in the Stock Market
  • Efficient Market Hypothesis: Strong Form
  • Efficient Markets
  • Posted on 30th July 2008
    Under: Active Management, Investing in Stocks, Investment Returns, Passive Management | No Comments »

    The Monte Carlo Method for Estimating Value at Risk (VaR)

    Using the Monte Carlo method to estimate Value at Risk (VaR) produces a set of random outcomes reflecting the effects of particular sets of risks. Each set of outcomes is based on a probability distribution for each variable of interest. The distributions for each variable can be normal or non-normal.

    Monte Carlo simulations are frequently the only method that provides a practical means to generate necessary risk management information. However, it can become quite a hog of computer resources for large portfolios.

    See also:
  • Monte Carlo Approach to Retirement Planning
  • The Analytical (Variance-Covariance) Method for Estimating Value at Risk (VaR)
  • The Historical Method for Estimating Value at Risk (VaR)
  • Estimating the Required Return on a Stock Using the Bond-Yield Plus Risk Premium Method
  • The Equity Risk Premium
  • Posted on 29th July 2008
    Under: Governance, Portfolio Management, Risk Management | No Comments »

    Escalation Bias

    In behavioral finance, escalation bias causes investors to invest more in money-losing investments for which they feel responsible than they invest in an ongoing successful investment. The popular concept of “averaging down” to reduce the average price paid for the investment may be representative of this bias.

    The rational, traditional finance model would expect investors to re-evaluate holdings for potential bad news that they had failed to incorporate into their initial valuation. If the re-evaluation supports the investment, then more could be added. Otherwise, it would be wiser to exit the position and take the loss.

    See also:
  • Overconfidence and Confirmation Bias
  • Data Measurement Errors and Biases
  • Self-attribution Bias and the Psychological Call Option
  • Biases in Detecting Efficient Market Anomalies
  • Overconfidence Bias
  • Posted on 29th July 2008
    Under: Behavioral Finance | No Comments »

    Performance Evaluation Issues Related to Hedge Funds

    A number of factors affect performance evaluation for hedge funds, particularly with respect to using the Sharpe ratio to measure risk-adjusted return.

    Starting with return, typically monthly returns are compounded to an annualized rate of return. However, entry and exit opportunities may be permitted only quarterly or even less frequently. In addition, some measures of downside risk such as the maximum drawdown are not compounded. Measures comparing return (compounded) and drawdown (not compounded) may not fully reflect the risk/return profile.

    The Sharpe ratio is defined as:

    • Numerator is the difference between annualized return and the annualized risk-free rate
    • Denominator is the annualized standard deviation of returns

    The Sharpe ratio increases proportionately with the square root of time, and is not appropriate when returns are asymmetrical. In particular, the Sharpe ratio tends to be overestimated when returns are serially correlated or assets are illiquid. Furthermore, the correlations between the fund and an investor’s other portfolio assets are not considered.

    There are a number of ways managers can “game” the Sharpe ratio, including:

    • Lengthening the measurement interval
    • Compounding monthly returns but calculating standard deviations without compounding
    • Writing out of money put or call options to produce asymmetric returns
    • Smoothing returns
    • Using swaps to eliminate extreme outlying returns

    In part because of these deficiencies, the Sharpe ratio has not been found to be a good predictor of hedge fund returns.

    See also:
  • Determinants of Funds of Hedge Funds Performance
  • Performance Evaluation
  • Choice of Performance Measure for Hedge Funds
  • Benchmarking Issues for Hedge Funds
  • Do Hedge Funds Deliver Alpha?
  • Posted on 28th July 2008
    Under: Active Management, Alternative Assets, Asset Allocation, Hedge Funds, Investment Returns, Portfolio Management | No Comments »

    ss_blog_claim=03ab3ad958d87eac8403bc8f2fe29a6d